29.3200.00% ( 0.000 )
Delay Suspended: Nov 17, 09:29:26Financials
Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: AB&B BIO-TECH-B(02627) the Revenue is 77.48 M (+980.8%);the EBIT is -33.05 M (+66.02%);the EPS is -0.104 (+62.29%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.08B980.75%
----
----
EBIT
-0.03B66.02%
----
----
EPS
-0.104162.29%
----
----
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
